Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and FOLFIRI in Ultra-selected Stage IV Colorectal Cancer
NCT01704703Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Oct 2012
- Primary completion
- Jul 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (CRC), sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Oct 2012; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01704703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704703.